SNN

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Smith & Nephew plc

CEO
Roland Diggelmann
Employees
18581
Headquarters

Hatters Lane
Watford, Hertfordshire WD18 8YE
Phone: 4401923477100
http://www.smith-nephew.com/

News

Smith & Nephew PLC. PT Raised to GBP16 at RBC Capital
Mar 14, 2023 08:20am

https://www.investing.com/news/pro/smith--nephew-plc-pt-raised-to-gbp16-at-rbc-capital-432SI-3029683


Source:Investing.com
Prolocor Announces Appointment of Edward L. Rosen to Its Board of Directors
Mar 09, 2023 14:00pm

PHILADELPHIA, PA / ACCESSWIRE / March 9, 2023 / Prolocor, Inc., a healthcare startup developing an innovative precision diagnostic test with the potential to predict the risk of thrombosis by quantifying FcγRIIa on the surface of platelets, today announced that Edward L. Rosen has joined the company''s Board of Directors. Rosen is a highly accomplished and well-respected industry expert and has held numerous senior-level positions during his illustrious career. Prolocor Logo Prolocor Logo Most recently, Rosen served as Chief Strategy & Commercial Officer at Clinical Genomics, where he generated and implemented an integrated commercial strategy, delivered successful IP licensing, and oversaw efforts that gained Medicare and Medicare Advantage reimbursement coverage. Prior to joining Clinical Genomics, he served as Executive-in-Residence at Columbia University (Office of Technology Ventures), where he collaborated with entrepreneurs and inventors to facilitate the transfer of research innovations from the lab to the market, as well as supporting start-up efforts across therapeutic, diagnostic and device applications.


Source:Accesswire
Smith & Nephew plc: Smith+Nephew''s VISIONAIRE Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation
Mar 06, 2023 13:06pm

LONDON, March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Pati…


Source:Finanz Nachrichten
Smith+Nephew''s VISIONAIRE Patient-Specific Instrumentation shown to improve outcome measures for total knee arthroplasty compared with conventional instrumentation
Mar 06, 2023 13:00pm

LONDON, March 6, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a systemic literature review and meta-analysis1 of its VISIONAIRE Patient-Specific Instrumentation (PSI) showing that its use leads to improvements in alignment…


Source:PR Newswire
Smith & Nephew: Flat FY22 Growth, Now An Execution Story (NYSE:SNN)
Feb 22, 2023 19:43pm

Smith & Nephew saw flat top-line growth, declines in earnings and CFFO relative to FY21. Click here to read my most recent analysis of SNN stock.


Source:Seeking Alpha
Smith & Nephew: Orthopedic Franchise Finally Coming Along
Feb 22, 2023 16:15pm

Smith & Nephew reports top-line growth in Q4. Innovation & operational leverage finally turning the screw here. Click here to see our take on SNN stock.


Source:Seeking Alpha
Smith & Nephew: Progress, But More Work Ahead In Ortho (NYSE:SNN)
Feb 22, 2023 14:37pm

Smith & Nephew plc has the technology to be more competitive in ortho and gain share in major joints and extremities. Click here to know more on SNN stock.


Source:Seeking Alpha
Smith & Nephew plc (SNN) Q4 2022 Earnings Call Transcript
Feb 22, 2023 02:50am

Smith & Nephew plc (NYSE:NYSE:SNN) Q4 2022 Earnings Conference Call February 21, 2023 3:30 AM ETCompany ParticipantsDeepak Nath - CEOAnne-Francoise Nesmes - CFOConference Call…


Source:Seeking Alpha
Smith & Nephew – Profits Slip But Trading Improving
Feb 21, 2023 19:20pm

In 2022, Smith & Nephew’s (LON:SN) like for like revenues were up 4.7% to $5.2bn, ignoring currency movements. This was helped by improved trading in the final quarter across all divisions, with Sports Medicine & ENT (Ear Nose and Throat) performing particularly strongly. A 4.1% increase in fourth quarter Orthopaedics revenues was driven by a […]


Source:ValueWalk
Smith & Nephew stock rises as Q4 revenue grows, sees macro headwinds in FY23
Feb 21, 2023 17:35pm

Smith & Nephew (SNN) stock rose ~6% on Tuesday after Q4 revenue grew and the company provided FY23 outlook.Q4 revenue grew 1.4% Y/Y to ~$1.37B. Revenue from Orthopaedics segment fell…


Source:Seeking Alpha
Smith & Nephew warns chip shortages still affecting medical industry
Feb 21, 2023 14:53pm

News, analysis and comment from the Financial Times, the worldʼs leading global business publication


Source:Financial Times
Smith & Nephew declares dividend
Feb 21, 2023 13:08pm

Smith & Nephew (SNN) board is recommending a final dividend of 23.1¢ per share (46.2¢ per ADS) (2021: 23.1¢ per share). Together with the interim dividend of 14.4¢ per share (28.8¢ per ADS)


Source:Seeking Alpha
Smith & Nephew reports drop in operating profit despite reaching annual revenue targets
Feb 21, 2023 10:39am

Medical equipment manufacturer Smith & Nephew has seen a drop in operating profit, with 2022 revenue hitting its $5.2bn forecast.


Source:Investomania
Smith & Nephew reports FY earnings; initiates FY23 guidance
Feb 21, 2023 07:56am

Smith & Nephew press release (SNN): FY GAAP EPS of $0.26 misses by $0.14.EPSA of $0.82.Revenue of $5.21B in-line (flat Y/Y).Cash generated from operations of $581M (2021: $1,048M)…


Source:Seeking Alpha
Smith+Nephew FY22 Profit Down, Maintains Dividend; Sees Growth In FY23; Updates Midterm View
Feb 21, 2023 07:42am

(RTTNews) - Medical technology company Smith & Nephew Plc (SN, SNN) reported Tuesday that its fiscal 2022 profit before taxation declined to $235 million from last year''s $586 million. Earnings per share were 25.5 US cents, down from 59.7 US cents a year ago. Earnings per ADS were 51.0 US cents. Adjusted earnings per share were 81.


Source:Business Insider Markets
Smith & Nephew SNATS, Inc. - Consensus Indicates Potential 29.4% Upside - DirectorsTalk Interviews
Feb 20, 2023 10:45am

Smith & Nephew SNATS, Inc. - Consensus Indicates Potential 29.4% Upside


Source:DirectorsTalk
Churchill’s grandson and Serco chief named new chair of Smith & Nephew
Feb 17, 2023 08:34am

The grandson of Sir Winston Churchill and chief executive of Serco has been unveiled as the new chair of 167-year-old medical tech firm Smith & Nephew. Rupert Soames will assume the position at the London-listed company following the retirement of Roberto Quarta, the firm announced, He will take the reins in late April during its […] The post Churchill’s grandson and Serco chief named new chair of Smith & Nephew appeared first on CityAM .


Source:City AM
Churchill''s grandson and Serco chief named new chair of Smith & Nephew
Feb 17, 2023 08:34am

The grandson of Sir Winston Churchill and chief executive of Serco has been unveiled as the new chair of 167-year-old medical tech firm Smith &


Source:City AM
Will Investors Notice Exciting Sign On Smith & Nephew''s Chart?
Jan 30, 2023 14:47pm

If history is any guide, there may be good fortune ahead for shares of Smith & Nephew (NYSE: SNN ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions. When a shorter-term average price crosses above a longer-term average price, it could mean the stock is trending … Full story available on Benzinga.com


Source:Benzinga
Smith+Nephew receives Innovative Technology designation from Vizient for LEAF™ Patient Monitoring System
Jan 30, 2023 13:00pm

Designation recognizes Vizient-contracted products that bring improvements to healthcare industry LONDON, Jan. 30, 2023 /PRNewswire/ -- Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces that its LEAF Patient Monitoring System has received an…


Source:PR Newswire
Pressure Ulcers Treatment Market to See Booming Growth 2023-2030 | Smith & Nephew PLC, Coloplast Group, ConvaTec Group PLC, B. Braun Melsungen AG
Jan 30, 2023 10:31am

Edition: 2023 The Global Pressure Ulcers Treatment Market Report provides In-depth analysis on the market status of the Pressure Ulcers Treatment Top manufacturers with best facts and figures, meaning, Definition, SWOT and PESTEL analysis, expert opinions and the latest developments across


Source:OpenPR